What is the GCH1 gene?
GCH1 contributes to BH4 support behind endothelial nitric-oxide production. That makes it more useful as part of a pathway view than as an isolated SNP call.
How GCH1 affects metabolism
If GCH1-related support is less favorable, the pathway can look more pressured under load and the linked biomarkers become more useful to validate directly.
What happens when GCH1 is altered
An altered GCH1 pattern does not diagnose anything on its own, but it does change which follow-up markers deserve attention first.
Curated SNP evidence for GCH1
These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.
Evidence-backed report connection
GCH1 currently has 2 curated SNPs, 9 claim-level scores, and 0 claims eligible for pathway scoring.
Open the sample reportrs3783641GCH1 supporting signal6 claims · 12 study rows
unknown · AA
GCH1 unscored target
rs3783641 AA has no scored directional claim for GCH1 unscored target.
rs3783641 is not scored here as a standalone GCH1 activity or biomarker marker. The available human evidence is mainly haplotype-based and not strong enough for a simple genotype effect.
Show study evidence
unknown · AC
GCH1 unscored target
rs3783641 AC has no scored directional claim for GCH1 unscored target.
rs3783641 is not scored here as a standalone GCH1 activity or biomarker marker. The available human evidence is mainly haplotype-based and not strong enough for a simple genotype effect.
Show study evidence
unknown · AT
GCH1 unscored target
rs3783641 AT has no scored directional claim for GCH1 unscored target.
rs3783641 is not scored here as a standalone GCH1 activity or biomarker marker. The available human evidence is mainly haplotype-based and not strong enough for a simple genotype effect.
Show study evidence
unknown · CC
GCH1 unscored target
rs3783641 CC has no scored directional claim for GCH1 unscored target.
rs3783641 is not scored here as a standalone GCH1 activity or biomarker marker. The available human evidence is mainly haplotype-based and not strong enough for a simple genotype effect.
Show study evidence
unknown · CT
GCH1 unscored target
rs3783641 CT has no scored directional claim for GCH1 unscored target.
rs3783641 is not scored here as a standalone GCH1 activity or biomarker marker. The available human evidence is mainly haplotype-based and not strong enough for a simple genotype effect.
Show study evidence
unknown · TT
GCH1 unscored target
rs3783641 TT has no scored directional claim for GCH1 unscored target.
rs3783641 is not scored here as a standalone GCH1 activity or biomarker marker. The available human evidence is mainly haplotype-based and not strong enough for a simple genotype effect.
Show study evidence
rs8007267GCH1 supporting signal3 claims · 6 study rows
unknown · CC
GCH1 unscored target
rs8007267 CC has no scored directional claim for GCH1 unscored target.
rs8007267 is treated as GCH1 haplotype context, not as a standalone activity or biomarker score. All genotypes are neutral in this simplified end-user file.
Show study evidence
unknown · CT
GCH1 unscored target
rs8007267 CT has no scored directional claim for GCH1 unscored target.
rs8007267 is treated as GCH1 haplotype context, not as a standalone activity or biomarker score. All genotypes are neutral in this simplified end-user file.
Show study evidence
unknown · TT
GCH1 unscored target
rs8007267 TT has no scored directional claim for GCH1 unscored target.
rs8007267 is treated as GCH1 haplotype context, not as a standalone activity or biomarker score. All genotypes are neutral in this simplified end-user file.
Show study evidence
Common symptoms people report
- nitric oxide / vascular tone can overlap with more persistent symptom patterns
- marker-driven follow-up may matter more than generic advice
- mixed responses can make the pathway easier to miss without structured review
Biomarkers to validate
Blood pressure context
Primary follow-up marker for GCH1 inside nitric oxide / vascular tone.
Related pathway markers
Useful when the pathway needs to be validated as a system rather than as one variant.
Where DNA analysis helps
DNA helps decide whether GCH1 should move nitric oxide / vascular tone higher on the follow-up list before broad interventions are assumed.
Example interpretation
GCH1 can strengthen the case for nitric oxide / vascular tone follow-up when the rest of the pathway points in a similar direction.
Suggested validation: Blood pressure context.
What to do next
- Use Blood pressure context and pathway context before assuming the gene matters in practice.
- Read GCH1 alongside the related genes in the same pathway instead of as a standalone result.
Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.
Get My DNA Report